2m 2m 2m 2m 2m 2m 2m
Corcept Therapeu (CORT)
NASDAQ
$81.29+$1.44 (+1.80%)
Price as of Jun 23, 2026 7:58 PM EDT- $8.6BMarket Cap
- 7.31%1-Year Change
- BiotechnologyIndustry
Corcept Therapeu (CORT)
$81.29+$1.44 (+1.80%)
CORT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $79.85 | ||
Change | -$0.20 (-0.25%) | ||
Open | $80.03 | ||
High | $82.31 | ||
Low | $79.22 | ||
Previous Close | $79.71 | ||
Volume | 947,295 | ||
30-Day Average Volume | 1,036,708 | ||
1-Week Change | -4.10% | ||
1-Month Change | 32.36% | ||
1-Year Change | 7.31% | ||
3-Year Change | 256.64% | ||
5-Year Change | 262.98% | ||
Fundamentals | |||
Shares Outstanding | 107.4M | ||
Total Assets | $814.9M | ||
Market Cap | $8.6B | ||
Enterprise Value | $8.4B | ||
Period: QTR TTM FY | |||
Revenue | $164.9M | ||
Net Income | -$31.8M | ||
Free Cash Flow | -$17.0M | ||
EBIT | -$44.7M | ||
EBITDA | -$44.1M | ||
Net Working Capital | $276.8M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -191 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 13 | ||
P/E | -266 | ||
PEG | 1 | ||
Price/Free Cash Flow | -504 | ||
Price/Operating Cash Flow | -510 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue